INTERNATIONAL PATENT: EURUS THERAPEUTICS INC., ＥＵＲＵＳ ＴＨＥＲＡＰＥＵＴＩＣＳ株式会社 FILES APPLICATION FOR "DOUBLE-STRANDED NUCLEOTIDE COMPLEX FOR MODIFICATION OF TARGET NUCLEOTIDE SEQUENCE"

GENEVA, May 11 -- EURUS THERAPEUTICS INC. (2-26-1, Muraoka Higashi, Fujisawa-shi, Kanagawa2518555), Ｅｕｒｕｓ　Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社 (神奈川県藤沢市村岡東２－２６－１) filed a patent application (PCT/JP2025/037871) for "DOUBLE-STRANDED NUCLEOTIDE COMPLEX FOR MODIFICATION OF TARGET NUCLEOTIDE SEQUENCE" on Oct 28, 2025. With publication no. WO/2026/094932, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Paten...